Do Not Wait for Final Culture - Consult Infectious Disease Now
You should consult infectious disease immediately upon detection of Staphylococcus aureus in a leg wound culture, even with rare growth, rather than waiting for final culture results. The presence of S. aureus in a wound culture is always clinically significant and warrants early specialist involvement to optimize outcomes and reduce mortality.
Why Early ID Consultation Matters
The evidence strongly supports early infectious disease consultation for S. aureus infections:
- Mortality reduction: ID consultation for S. aureus infections reduces 30-day mortality by nearly half (12.39% vs 26.07%, RR 0.53) 1
- Improved management: ID involvement increases appropriate antibiotic selection (RR 1.14), ensures adequate treatment duration (RR 1.85), and increases performance of essential follow-up blood cultures (RR 1.35) and echocardiography (RR 1.98) 1
- Guideline recommendation: Diabetic foot infection guidelines explicitly state that the multidisciplinary team "should preferably include, or have ready access to, an infectious diseases specialist" 2
Clinical Reasoning for Immediate Consultation
Even "rare growth" of S. aureus requires attention because:
S. aureus is never a contaminant in wound cultures - its presence indicates true infection requiring targeted therapy 3
Risk of complications is substantial - S. aureus causes metastatic infection in >33% of bacteremia cases, including endocarditis (12%), septic arthritis (7%), and osteomyelitis (4%) 3
MRSA prevalence requires early consideration - You need to determine if empiric MRSA coverage is warranted based on patient risk factors (prior MRSA history, recent antibiotics, local prevalence) while awaiting susceptibilities 4
Source control decisions are time-sensitive - ID specialists help determine if surgical debridement, abscess drainage, or other interventions are needed 2
What to Do While Awaiting ID Consultation
Start empiric antibiotics immediately - do not wait for final susceptibilities:
- For mild-moderate infections without recent antibiotic exposure: Coverage targeting gram-positive cocci (e.g., cephalexin, cefazolin) may suffice 4
- For moderate-severe infections or recent antibiotic use: Include empiric MRSA coverage (vancomycin, daptomycin, or linezolid) 5
- Consider MRSA coverage if: prior MRSA history, local MRSA prevalence >30%, or severe infection 4
Obtain proper wound care:
- Debride necrotic tissue
- Implement pressure off-loading for lower extremity wounds
- Ensure adequate wound cleansing 2
Arrange follow-up cultures if not already done - ensure the specimen was obtained properly (tissue biopsy or curettage after debridement, not superficial swab) 4
Common Pitfalls to Avoid
- Don't dismiss "rare growth" - any S. aureus isolation is clinically relevant and requires treatment 3
- Don't wait for "final" results - preliminary culture showing S. aureus is sufficient to trigger consultation 1
- Don't assume antibiotics alone are sufficient - wound care and potential surgical intervention are equally critical 2
- Don't forget to assess for deeper infection - consider imaging for osteomyelitis if bone is exposed or probed, or if infection is chronic 4
The 50% mortality reduction associated with ID consultation for S. aureus infections 1 makes early involvement a critical intervention that directly impacts patient survival and limb salvage.